𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain

✍ Scribed by Thomas Forst; Terry Smith; Klemens Schütte; Paul Marcus; Andreas Pfützner; for the CNS 5161 Study Group


Book ID
108641818
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
214 KB
Volume
64
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.